SlideShare a Scribd company logo
MENOPAUSE & HRT
DEFINITION
● MENOPAUSE is defined as,
“The woman’s final menstrual period and the accepted
confirmation of this is made retrospectively after 1 year of amenorrhea”.
CAUSE: cessation of regular ovarian function.
PERIMENOPAUSE: The time of life from the onset of ovarian dysfunction until 1 year
after the last period and the diagnosis of menopause is made. This time is also known
as climacteric.
POSTMENOPAUSAL:
All the women who have been 1 year since their last period are
deemed postmenopausal.
The “CHANGE”:
A colloquial discription of Perimenopause and Postmenopause.
TYPES
● PHYSIOLOGICAL(occurring at a median age
age of between 51 to 52 years).
● NON PHYSIOLOGICAL
(occurring before 40 years).
Non-physiological
1. Premature ovarian
insufficiency
2. Iatrogenic menopause
A.medical treatment
B.
Surgical menopause
ENDOCRINE CHANGES
Menopause occurs at the time of depletion of oocytes from the ovary and is irreversible.
Hormones that maintain reproductive function
● GnRH(by hypothalamus)
● LH and FSH(pituitary)
● Inhibin(ovarian follicles)
● Steroids (estrogen, progesterone, testosterone(ovaries, peripheral adipose tissue, adrenal
gland)
Female hormone production and changes
around the menopausal years
Hormones Perimenopause Early postmenopause Late postmenopause
GnRH Increased pulsatility Progressive decrease in
pulsatility
Reduction in overall
levels
LH&FSH Increased Increased Progressive decline
Oestrogen Slight decline Rapid decline in levels Sustained very low levels
Progesterone Moderate falls Unpredictable Undetectable
Inhibin Slight decline Significant decline Undetectable
Testosterone Progressive decline Progressive decline Sustained low levels
Non physiological menopause
Premature ovarian insufficiency
● Before 40 years
● Premature ovarian failure
● Supportive care counseling by
Specialist unit.
● Gamete donation
Primary • Chromosomal
Abnormalities(turner
, fragile X)
• Autoimmume(hypot
hyroidism, Addison,
myasthenia gravis)
• Enzyme deficiencies
(Galactosemia, 17
@-hydroxylase
deficiency
Secondary Chemotherapy or
radiotherapy,
infections(mumps, TB,
varicella, malaria).
Medical treatment associated menopause
● Chemotherapy
● Radiotherapy
● GnRH Agonists (buserelin , goseralin )
● Backup therapy (hormones and drugs)
● Surgical procedures to treat gynecological problems
● Menstrual disorders, fibroid, endometriosis
● BSO(Bilateral salpingoophorectomy (high risk women🡪 breast and ovarian cancer, BRCA1and 2
gene mutation screening.
● planning
effects of menopause by time of onset
Immediate (0-5 years) Vasomotor symptoms(hot flushes, night sweats)
Psychological symptoms (labial mood, anxiety,
tearfulness)
Loss of concentration, poor memory, joint ache
and pain
Dry and itchy skin
Hair changes decrease sexual desire
Intermediate(3-10years) Vaginal dryness, soreness
Dysparunia, urinary urgency
Recurrent UTI
Long term(>10 years) Osteoporosis, CVS dirorders, dementia
CNS Symptoms
Vasomotor
● Mostly during perimenopausal Period
● Hot flushes, night sweat(loss of modulating effect of estrogen on serotinergic
receptors within thermoregulatory Centre in brain exagerrated peripheral
vasodialtory response to minor atmospheric changes)
● Sleep disturbance poor performance and quality of life.
Psychological symptoms
● Tiredness
● Anxiety and depression
Cognitive function
● Memory changes
THE GENITAL TRACT
Changes in menstrual bleeding
Endometrial effects
Initially scanty bleeding because of low estrogenic endometrial stimulation and then completely
stop.
Urogenital and vulvovaginal atrophy
● Vaginal dryness, burning, irritation, Dysparunia, shrinkage and fusion of labia and narrowing of
vaginal introitus.
● Loss of oestrogenic support🡪 Vaginal epithelium less elastic, more easily traumatized
● Incontinence , prolapse, urogynaecological problems
Bone health
● Loss of estrogenic support on skeleton🡪 osteoporotic fractures
● Bone formation(osteoblasts) decreases and bone destruction increases(osteoclasts). Bone
density peaks at 20 to 30 then declines afterwards then a steady decline till menopause then
accelerated loss until 60 years then further steady decline till death.
disorder characterized by compromised bone strength predisposing to an increased risk of
fracture. Male to female ratio 1:4
RISK FACTORS FOR OSTEOPOROSIS
1-Family history 4-long term steroid use 7-Disorders of thyroid
and parathyroid
metabolism
2-smoking 5-POI and hypogonadism 8-immobility
3-Alcoholism 6-Medical treatment of
gynecological conditions
with induced menopause
9-disorders of gut
absorption, Malnutrition,
liver diseses.
CVS symptoms
● Due to low estrogen following changes are observed
1. Incresed TAGs, total cholesterol, LDL and reduction in HDL
2. Femlae physiology changes, nutrition, exercise, changes in fat distribution from
a more gynaecoid to android .
3. Loss of estrogenic support on vessel walls(^atherogenesis)
Management of menopause
● Treatment options
1. Non Pharmacological
- Lifestyle modification
- Natural herbs & remedies
- Diet & suppliments, vit C, E
2. Pharmacological
- Hormone replacement therapy (HRT)
- Alpha 2 agonist
- Beta blockers
- Gabapentin
Hormone replacement therapy (HRT)
● Includes a wide range of hormonal products(estrogen, progesterone,
androgens, tibolone) with various methods & routes of administration,
potentially different risks and benefits .
Evaluation before starting HRT
● History and physical examination
● BP measurement
● Breast and pelvic examination
● Serum TSH (T4 > 500mg/dl absolute C/I for HRT)
● Mammography
● Lipid profile
● Baseline USG
Standard HRT
If uterus present:
Estrogen + progesterone
If uterus absent:
Estrogen alone ( except history of endometrial cancer, h/o Endometriosis, h/o
endometroid tumor of ovary , in such cases estrogen + progesterone is given).
If estrogen C/I : SSRI’s and SNRI’s
Advantages of HRT
● Relieve from hot flashes, mood swings, vaginal dryness
● Relieve from genitourinary symptoms
● Prevention of osteopetrosis
● Decreased risk of colon cancer
Disadvantages of HRT
● Risk of coronary artery disease
● Risk of breast cancer
● Risk of venous thromboembolism
● Risk of endometrial cancer
● Risk of ovarian cancer
● Risk of gallstones and cholecystitis
Contraindications of HRT
Absolute Relative
- Pregnancy/ breastfeeding - h/o of benign breast disease
- Endometrial cancer - large uterine fibroids
- Current Venous thromboembolism - unexplained vaginal bleeding
- Active liver disease - Migraine/ headaches
Side effects of HRT
● Oestrogen Progesterone
- Breast tenderness - PMS like symptoms
- Leg cramps - Breakthrough bleeding
- Nausea - Breast tenderness
- Depression mood swings
Menopause & HRT1.pptx

More Related Content

Similar to Menopause & HRT1.pptx

Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Lifecare Centre
 
Menopause overview
Menopause overviewMenopause overview
Menopause overview
Hanifullah Khan
 
Pharmacology of gynecology satya
Pharmacology of  gynecology satyaPharmacology of  gynecology satya
Pharmacology of gynecology satya
sathyanarayanan varadarajan
 
hormonal replacement therapy.pptx
hormonal replacement therapy.pptxhormonal replacement therapy.pptx
hormonal replacement therapy.pptx
hemachandra59
 
Menopause & HRT
Menopause & HRTMenopause & HRT
Menopause & HRT
priyadharshini manickam
 
Precious Puberty
Precious PubertyPrecious Puberty
Menopause management seminar
Menopause management seminarMenopause management seminar
Menopause management seminarobsgynhsnz
 
Dysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptx
Dysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptxDysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptx
Dysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptx
Rani ambrose
 
Menopause
MenopauseMenopause
Menopause
KHUSHBU PATEL
 
Step by step menopause hormone therapy by Dr Alka Mukherjee
Step by step menopause hormone therapy by Dr Alka MukherjeeStep by step menopause hormone therapy by Dr Alka Mukherjee
Step by step menopause hormone therapy by Dr Alka Mukherjee
alka mukherjee
 
Menopause and-physical-therapy-role-for-its-related-disorders (1)
Menopause and-physical-therapy-role-for-its-related-disorders (1)Menopause and-physical-therapy-role-for-its-related-disorders (1)
Menopause and-physical-therapy-role-for-its-related-disorders (1)
South Valley University, Egypt and Queen's University, Ontario
 
menupause & HRT s.ppsx
menupause & HRT s.ppsxmenupause & HRT s.ppsx
menupause & HRT s.ppsx
Ahmedalmahdi16
 
MENOPAUSE AND HRT finall From AIIMS .pptx
MENOPAUSE AND HRT finall From AIIMS .pptxMENOPAUSE AND HRT finall From AIIMS .pptx
MENOPAUSE AND HRT finall From AIIMS .pptx
ssuserac8367
 
Understanding Menopause
Understanding Menopause Understanding Menopause
Understanding Menopause
schhasatia
 
Hormonal presentation
Hormonal presentationHormonal presentation
Hormonal presentation
hina613291
 
The fertility cure
The fertility cureThe fertility cure
The fertility cure
Patrick Garrett, DC
 

Similar to Menopause & HRT1.pptx (20)

Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
Key points in prescription writing in menopause, Dr. Sharda Jain, Dr. Jyoti A...
 
Sex hormone lab
Sex hormone labSex hormone lab
Sex hormone lab
 
Menopause
MenopauseMenopause
Menopause
 
Menopause overview
Menopause overviewMenopause overview
Menopause overview
 
Pharmacology of gynecology satya
Pharmacology of  gynecology satyaPharmacology of  gynecology satya
Pharmacology of gynecology satya
 
L49 Menopause
L49 MenopauseL49 Menopause
L49 Menopause
 
hormonal replacement therapy.pptx
hormonal replacement therapy.pptxhormonal replacement therapy.pptx
hormonal replacement therapy.pptx
 
Menopause & HRT
Menopause & HRTMenopause & HRT
Menopause & HRT
 
Precious Puberty
Precious PubertyPrecious Puberty
Precious Puberty
 
Menopause management seminar
Menopause management seminarMenopause management seminar
Menopause management seminar
 
Dysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptx
Dysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptxDysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptx
Dysmenorrhoea, PMS, Vaginal discharge, Mastitis.pptx
 
Menopause
MenopauseMenopause
Menopause
 
Step by step menopause hormone therapy by Dr Alka Mukherjee
Step by step menopause hormone therapy by Dr Alka MukherjeeStep by step menopause hormone therapy by Dr Alka Mukherjee
Step by step menopause hormone therapy by Dr Alka Mukherjee
 
Menopause and-physical-therapy-role-for-its-related-disorders (1)
Menopause and-physical-therapy-role-for-its-related-disorders (1)Menopause and-physical-therapy-role-for-its-related-disorders (1)
Menopause and-physical-therapy-role-for-its-related-disorders (1)
 
menupause & HRT s.ppsx
menupause & HRT s.ppsxmenupause & HRT s.ppsx
menupause & HRT s.ppsx
 
Menopause
MenopauseMenopause
Menopause
 
MENOPAUSE AND HRT finall From AIIMS .pptx
MENOPAUSE AND HRT finall From AIIMS .pptxMENOPAUSE AND HRT finall From AIIMS .pptx
MENOPAUSE AND HRT finall From AIIMS .pptx
 
Understanding Menopause
Understanding Menopause Understanding Menopause
Understanding Menopause
 
Hormonal presentation
Hormonal presentationHormonal presentation
Hormonal presentation
 
The fertility cure
The fertility cureThe fertility cure
The fertility cure
 

More from BuzzTera

CERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptxCERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptx
BuzzTera
 
Uterine cancer 20 september 2022.pptx
Uterine cancer  20 september 2022.pptxUterine cancer  20 september 2022.pptx
Uterine cancer 20 september 2022.pptx
BuzzTera
 
PPH.pptx
PPH.pptxPPH.pptx
PPH.pptx
BuzzTera
 
Surah Hujurat 11-18.pdf
Surah Hujurat 11-18.pdfSurah Hujurat 11-18.pdf
Surah Hujurat 11-18.pdf
BuzzTera
 
neonatal resuscitation final.pptx
neonatal resuscitation final.pptxneonatal resuscitation final.pptx
neonatal resuscitation final.pptx
BuzzTera
 
229814.ppt
229814.ppt229814.ppt
229814.ppt
BuzzTera
 
Antepartum Haemorrhage.pptx
Antepartum Haemorrhage.pptxAntepartum Haemorrhage.pptx
Antepartum Haemorrhage.pptx
BuzzTera
 
UTEROVAGINAL PR-WPS Office.pptx
UTEROVAGINAL PR-WPS Office.pptxUTEROVAGINAL PR-WPS Office.pptx
UTEROVAGINAL PR-WPS Office.pptx
BuzzTera
 

More from BuzzTera (8)

CERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptxCERVICAL CANCER-1.pptx
CERVICAL CANCER-1.pptx
 
Uterine cancer 20 september 2022.pptx
Uterine cancer  20 september 2022.pptxUterine cancer  20 september 2022.pptx
Uterine cancer 20 september 2022.pptx
 
PPH.pptx
PPH.pptxPPH.pptx
PPH.pptx
 
Surah Hujurat 11-18.pdf
Surah Hujurat 11-18.pdfSurah Hujurat 11-18.pdf
Surah Hujurat 11-18.pdf
 
neonatal resuscitation final.pptx
neonatal resuscitation final.pptxneonatal resuscitation final.pptx
neonatal resuscitation final.pptx
 
229814.ppt
229814.ppt229814.ppt
229814.ppt
 
Antepartum Haemorrhage.pptx
Antepartum Haemorrhage.pptxAntepartum Haemorrhage.pptx
Antepartum Haemorrhage.pptx
 
UTEROVAGINAL PR-WPS Office.pptx
UTEROVAGINAL PR-WPS Office.pptxUTEROVAGINAL PR-WPS Office.pptx
UTEROVAGINAL PR-WPS Office.pptx
 

Recently uploaded

Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 

Recently uploaded (20)

Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 

Menopause & HRT1.pptx

  • 2. DEFINITION ● MENOPAUSE is defined as, “The woman’s final menstrual period and the accepted confirmation of this is made retrospectively after 1 year of amenorrhea”. CAUSE: cessation of regular ovarian function. PERIMENOPAUSE: The time of life from the onset of ovarian dysfunction until 1 year after the last period and the diagnosis of menopause is made. This time is also known as climacteric.
  • 3. POSTMENOPAUSAL: All the women who have been 1 year since their last period are deemed postmenopausal. The “CHANGE”: A colloquial discription of Perimenopause and Postmenopause.
  • 4. TYPES ● PHYSIOLOGICAL(occurring at a median age age of between 51 to 52 years). ● NON PHYSIOLOGICAL (occurring before 40 years). Non-physiological 1. Premature ovarian insufficiency 2. Iatrogenic menopause A.medical treatment B. Surgical menopause
  • 5. ENDOCRINE CHANGES Menopause occurs at the time of depletion of oocytes from the ovary and is irreversible. Hormones that maintain reproductive function ● GnRH(by hypothalamus) ● LH and FSH(pituitary) ● Inhibin(ovarian follicles) ● Steroids (estrogen, progesterone, testosterone(ovaries, peripheral adipose tissue, adrenal gland)
  • 6. Female hormone production and changes around the menopausal years
  • 7. Hormones Perimenopause Early postmenopause Late postmenopause GnRH Increased pulsatility Progressive decrease in pulsatility Reduction in overall levels LH&FSH Increased Increased Progressive decline Oestrogen Slight decline Rapid decline in levels Sustained very low levels Progesterone Moderate falls Unpredictable Undetectable Inhibin Slight decline Significant decline Undetectable Testosterone Progressive decline Progressive decline Sustained low levels
  • 8. Non physiological menopause Premature ovarian insufficiency ● Before 40 years ● Premature ovarian failure ● Supportive care counseling by Specialist unit. ● Gamete donation Primary • Chromosomal Abnormalities(turner , fragile X) • Autoimmume(hypot hyroidism, Addison, myasthenia gravis) • Enzyme deficiencies (Galactosemia, 17 @-hydroxylase deficiency Secondary Chemotherapy or radiotherapy, infections(mumps, TB, varicella, malaria).
  • 9. Medical treatment associated menopause ● Chemotherapy ● Radiotherapy ● GnRH Agonists (buserelin , goseralin ) ● Backup therapy (hormones and drugs) ● Surgical procedures to treat gynecological problems ● Menstrual disorders, fibroid, endometriosis ● BSO(Bilateral salpingoophorectomy (high risk women🡪 breast and ovarian cancer, BRCA1and 2 gene mutation screening. ● planning
  • 10. effects of menopause by time of onset Immediate (0-5 years) Vasomotor symptoms(hot flushes, night sweats) Psychological symptoms (labial mood, anxiety, tearfulness) Loss of concentration, poor memory, joint ache and pain Dry and itchy skin Hair changes decrease sexual desire Intermediate(3-10years) Vaginal dryness, soreness Dysparunia, urinary urgency Recurrent UTI Long term(>10 years) Osteoporosis, CVS dirorders, dementia
  • 11. CNS Symptoms Vasomotor ● Mostly during perimenopausal Period ● Hot flushes, night sweat(loss of modulating effect of estrogen on serotinergic receptors within thermoregulatory Centre in brain exagerrated peripheral vasodialtory response to minor atmospheric changes) ● Sleep disturbance poor performance and quality of life.
  • 12. Psychological symptoms ● Tiredness ● Anxiety and depression Cognitive function ● Memory changes THE GENITAL TRACT Changes in menstrual bleeding Endometrial effects Initially scanty bleeding because of low estrogenic endometrial stimulation and then completely stop.
  • 13. Urogenital and vulvovaginal atrophy ● Vaginal dryness, burning, irritation, Dysparunia, shrinkage and fusion of labia and narrowing of vaginal introitus. ● Loss of oestrogenic support🡪 Vaginal epithelium less elastic, more easily traumatized ● Incontinence , prolapse, urogynaecological problems Bone health ● Loss of estrogenic support on skeleton🡪 osteoporotic fractures ● Bone formation(osteoblasts) decreases and bone destruction increases(osteoclasts). Bone density peaks at 20 to 30 then declines afterwards then a steady decline till menopause then accelerated loss until 60 years then further steady decline till death.
  • 14. disorder characterized by compromised bone strength predisposing to an increased risk of fracture. Male to female ratio 1:4 RISK FACTORS FOR OSTEOPOROSIS 1-Family history 4-long term steroid use 7-Disorders of thyroid and parathyroid metabolism 2-smoking 5-POI and hypogonadism 8-immobility 3-Alcoholism 6-Medical treatment of gynecological conditions with induced menopause 9-disorders of gut absorption, Malnutrition, liver diseses.
  • 15. CVS symptoms ● Due to low estrogen following changes are observed 1. Incresed TAGs, total cholesterol, LDL and reduction in HDL 2. Femlae physiology changes, nutrition, exercise, changes in fat distribution from a more gynaecoid to android . 3. Loss of estrogenic support on vessel walls(^atherogenesis)
  • 16.
  • 17. Management of menopause ● Treatment options 1. Non Pharmacological - Lifestyle modification - Natural herbs & remedies - Diet & suppliments, vit C, E 2. Pharmacological - Hormone replacement therapy (HRT) - Alpha 2 agonist - Beta blockers - Gabapentin
  • 18. Hormone replacement therapy (HRT) ● Includes a wide range of hormonal products(estrogen, progesterone, androgens, tibolone) with various methods & routes of administration, potentially different risks and benefits .
  • 19.
  • 20. Evaluation before starting HRT ● History and physical examination ● BP measurement ● Breast and pelvic examination ● Serum TSH (T4 > 500mg/dl absolute C/I for HRT) ● Mammography ● Lipid profile ● Baseline USG
  • 21. Standard HRT If uterus present: Estrogen + progesterone If uterus absent: Estrogen alone ( except history of endometrial cancer, h/o Endometriosis, h/o endometroid tumor of ovary , in such cases estrogen + progesterone is given). If estrogen C/I : SSRI’s and SNRI’s
  • 22. Advantages of HRT ● Relieve from hot flashes, mood swings, vaginal dryness ● Relieve from genitourinary symptoms ● Prevention of osteopetrosis ● Decreased risk of colon cancer
  • 23. Disadvantages of HRT ● Risk of coronary artery disease ● Risk of breast cancer ● Risk of venous thromboembolism ● Risk of endometrial cancer ● Risk of ovarian cancer ● Risk of gallstones and cholecystitis
  • 24. Contraindications of HRT Absolute Relative - Pregnancy/ breastfeeding - h/o of benign breast disease - Endometrial cancer - large uterine fibroids - Current Venous thromboembolism - unexplained vaginal bleeding - Active liver disease - Migraine/ headaches
  • 25. Side effects of HRT ● Oestrogen Progesterone - Breast tenderness - PMS like symptoms - Leg cramps - Breakthrough bleeding - Nausea - Breast tenderness - Depression mood swings